[go: up one dir, main page]

DE69829570D1 - Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung - Google Patents

Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung

Info

Publication number
DE69829570D1
DE69829570D1 DE69829570T DE69829570T DE69829570D1 DE 69829570 D1 DE69829570 D1 DE 69829570D1 DE 69829570 T DE69829570 T DE 69829570T DE 69829570 T DE69829570 T DE 69829570T DE 69829570 D1 DE69829570 D1 DE 69829570D1
Authority
DE
Germany
Prior art keywords
surfactant
disposal
compositions
production
active substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69829570T
Other languages
English (en)
Other versions
DE69829570T2 (de
Inventor
V Kabanov
Adi Eisenberg
A Kabanov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nebraska Lincoln
Original Assignee
University of Nebraska Lincoln
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nebraska Lincoln filed Critical University of Nebraska Lincoln
Application granted granted Critical
Publication of DE69829570D1 publication Critical patent/DE69829570D1/de
Publication of DE69829570T2 publication Critical patent/DE69829570T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
DE69829570T 1997-06-13 1998-06-11 Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung Expired - Fee Related DE69829570T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5300097P 1997-06-13 1997-06-13
US53000P 1997-06-13
PCT/US1998/012139 WO1998056334A1 (en) 1997-06-13 1998-06-11 Compositions for delivery of biological agents and methods for the preparation thereof

Publications (2)

Publication Number Publication Date
DE69829570D1 true DE69829570D1 (de) 2005-05-04
DE69829570T2 DE69829570T2 (de) 2006-02-16

Family

ID=21981274

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69829570T Expired - Fee Related DE69829570T2 (de) 1997-06-13 1998-06-11 Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung

Country Status (7)

Country Link
EP (1) EP1005324B1 (de)
JP (1) JP2002504123A (de)
AT (1) ATE291929T1 (de)
AU (1) AU8067198A (de)
CA (1) CA2294334A1 (de)
DE (1) DE69829570T2 (de)
WO (1) WO1998056334A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803517A1 (fr) * 2000-01-12 2001-07-13 Biovector Therapeutics Sa Matrices plymeriques amphiphiles et ioniques et derives de telles matrices
FR2803526A1 (fr) * 2000-01-12 2001-07-13 Biovector Therapeutics Matrices polymeriques amphiphiles et ioniques et derives de telles matrices
KR100566911B1 (ko) * 2001-06-25 2006-04-03 주식회사 삼양사 약물 전달체용 음이온기-함유 양친성 블록 공중합체 및 그의 양이온성 약물과의 복합체
WO2003074090A2 (en) 2002-03-07 2003-09-12 Biocompatibles Uk Limited Compositions of polymers
US7332527B2 (en) 2003-05-16 2008-02-19 Board Of Regents Of The University Of Nebraska Cross-linked ionic core micelles
WO2004105799A1 (ja) * 2003-05-29 2004-12-09 Toudai Tlo, Ltd. 安定化高分子ミセル
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
DK1758590T3 (da) 2004-05-19 2011-11-21 Los Angeles Biomed Res Inst Anvendelse af et detergent til ikke-kirurgisk fjernelse af fedt
US7754230B2 (en) 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
JP5835741B2 (ja) 2010-02-26 2015-12-24 国立大学法人 長崎大学 抗原または薬物送達複合体
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
WO2012138730A1 (en) 2011-04-04 2012-10-11 Board Of Regents Of The University Of Nebraska Drug delivery compositions and methods
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
CN118255984B (zh) * 2024-04-08 2025-02-11 临沂中磷生物科技有限公司 一种促生根的聚谷氨酸衍生物的制备方法、装置及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR940003548U (ko) * 1992-08-14 1994-02-21 김형술 세탁물 건조기
JPH08165491A (ja) * 1994-12-16 1996-06-25 Lion Corp 高分子とアニオン界面活性剤との複合体

Also Published As

Publication number Publication date
AU8067198A (en) 1998-12-30
ATE291929T1 (de) 2005-04-15
DE69829570T2 (de) 2006-02-16
JP2002504123A (ja) 2002-02-05
EP1005324A4 (de) 2001-06-06
EP1005324B1 (de) 2005-03-30
WO1998056334A1 (en) 1998-12-17
EP1005324A1 (de) 2000-06-07
CA2294334A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
DE69829570D1 (de) Zusammensetzungen zur abgabe von biologischen wirkstoffen und verfahren zu ihrer herstellung
DE68908211D1 (de) Dispersionsmittel fuer zement, verfahren zu ihrer herstellung und verfahren zum verleihen von fluidisierungseigenschaften an diese mittel enthaltende hydraulische zementzusammensetzungen.
DE69942610D1 (de) Die bindung von integrinen zu deren rezeptoren verhindernde verbindungen
DE69620832D1 (de) Zementdispersionsmittel, Verfahren zu seiner Herstellung und dieses Dispersionsmittel enthaltende Zementzusammensetzung
MY113045A (en) Waste treatment plant and process
DE69635496D1 (de) Verfahren und zusammensetzung zur vorbeugung und behandlung von mit clostridium difficile assoziierten erkrankungen
DE3381680D1 (de) 1,4-dihydropyridincarbonsaeure-ester, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE69033994D1 (de) Flüssige Polymerzusammensetzung und Verfahren zu ihrer Verwendung
HUT66197A (en) Composition based on alkyl polyglycosides which are usable for conditioning materials containing keratine, as well as using thereof for hair-washing and hair-conditioning
CA2210971A1 (en) Personal treatment compositions and/or cosmetic compositions containing enduring perfume
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
EA200100024A1 (ru) Состав таблетки с делавирдином
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
DE69002863D1 (de) Galliumteilchen enthaltende flüssige Suspensionszusammensetzung und Verfahren zu ihrer Herstellung.
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
DE69614110D1 (de) Stabilisierte pseudoemulsionen und verfahren zu ihrer herstellung
ATE293595T1 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
ATE264332T1 (de) Galanthamin-derivate, verfahren zu ihrer herstellung, ihre verwendung als arzmittel und diese enthaltende pharmazeutische zusammensetzung
DE59010759D1 (de) 3-Aminopyrrole, Verfahren zu ihrer Herstellung und ihre Verwendung als Antikonvulsiva
DE69613395D1 (de) Schwefelenthaltende di-ter-butylphenol-verbindungen brauchbar als entzündungshemmende mittel
DE69705967D1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
EP0370382A3 (de) Renin-hemmende Harnstoffderivate von Dipeptiden, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
DE59607683D1 (de) Neue borneolderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung
DE69620928D1 (de) Physiologisch aktive Substanzen PF1092A, PF1092B, und PF1092C, Verfahren zu deren Herstellung, sowie diese als aktive Bestandteile enthaltende empfängnisverhütende Mittel und Antikrebsmittel
WO1997008931A3 (de) Extraktionsmittel für polyhydroxyalkansäuren

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee